Advertisement
UK markets close in 6 hours 32 minutes
  • FTSE 100

    8,301.92
    +88.43 (+1.08%)
     
  • FTSE 250

    20,377.32
    +212.78 (+1.06%)
     
  • AIM

    776.95
    +5.42 (+0.70%)
     
  • GBP/EUR

    1.1649
    -0.0010 (-0.09%)
     
  • GBP/USD

    1.2540
    -0.0024 (-0.19%)
     
  • Bitcoin GBP

    51,253.38
    -891.03 (-1.71%)
     
  • CMC Crypto 200

    1,333.12
    -32.00 (-2.34%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.79
    +0.31 (+0.40%)
     
  • GOLD FUTURES

    2,324.00
    -7.20 (-0.31%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,259.12
    +83.91 (+0.46%)
     
  • CAC 40

    8,016.32
    +19.68 (+0.25%)
     

What’s Been Dragging Down CymaBay Therapeutics Stock

What’s Been Dragging Down CymaBay Therapeutics Stock

CymaBay Therapeutics (CBAY) closed at $6.17 on June 12, 1.98% higher than its previous close, 28.01% above its 52-week low of $4.82, and 58.87% below its 52-week high of $15.